{"id":"https://genegraph.clinicalgenome.org/r/3b18fc0a-61e9-443c-949f-28dcdd3c3b50v1.0","type":"EvidenceStrengthAssertion","dc:description":"DNAJC7 was first reported in relation to amyotrophic lateral sclerosis (ALS) in 2019 (Farhan et al., PMID: 31768050). This seminal discovery reported a significant excess of rare protein-truncating variants in ALS using whole-exome sequencing data from cases (n=5,095) compared to controls (n=28,910) in a single-gene burden analysis (OR=96.9; P=2.5x10^-7). One additional protein truncating (nonsense) variant has since been reported in one sporadic ALS case (PMID: 33062890). The mechanism of pathogenicity is reported to be loss of function (LoF). This gene-disease association is also supported by experimental evidence from expression studies showing expression if DNAJC7 in the brain and specifically neurons (PMID: 25613900), as well as a physical protein interaction with the definitive ALS gene/protein FUS (PMID: 26344197). \n\nIn summary, to-date there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen ALS GCEP on the meeting date October 27, 2022 (SOP Version 9). \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3b18fc0a-61e9-443c-949f-28dcdd3c3b50","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2022-12-20T21:35:33.404Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2022-10-27T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ed6e987-2949-426b-9f54-f231517ef586","type":"EvidenceLine","dc:description":"CCNF implicated as a \"limited\" evidence gene for ALS, the ALS GCEP has decided only interactions with definitive ALS genes will be scored in this category.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90ae75dd-4f54-4f8c-8e19-858dcd4daace","type":"Finding","dc:description":"Immunoprecipitation of CCNF transfected HEK293T cells coupled with mass spectrometry identified that DNAJC7 is an interaction partner of CCNF.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33729478","rdfs:label":"DNAJC7 is an interacting partner of CCNF","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7337695a-6a9e-41bd-8987-4d2c4ced1808","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20b19c0f-e280-4646-aaf8-3cf62dc5aa65","type":"Finding","dc:description":"High-performance liquid chromatography tandem mass spectrometry (LCâ€“MS/MS) of digested protein fractions of each human and mouse cell lines coupled with machine learning identified that DNAJC7 is an interacting partner of FUS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26344197","rdfs:label":"DNAJC7 is an interacting partner of FUS","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/514c70a2-e6b0-4f06-babc-3301bfc8fa3c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a27b5618-5114-4b1e-87ee-a0b812a658fe","type":"Finding","dc:description":"RNA-seq data and protein expression, including immunohistochemistry of cerebral cortex tissues from adults demonstrate the presence of DNAJC7 in various brain regions and specifically within neurons.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"RNA AND PROTEIN EXPRESSION OF DNAJC7 IN THE BRAIN ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7f8b1a7d-fe40-4e56-bda4-4aaa9fb1a361","type":"EvidenceLine","dc:description":"Score downgraded to reflect that a single patient was used in this experiment, and that this patient carries a protein truncating variant in the gene/protein of interest.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86182001-a1e9-4ace-a578-c99a7d5978de","type":"Finding","dc:description":"Western blot analysis of human fibroblast lysates demonstrated a significantly lower level of DNAJC7 protein in an ALS patient carrying a DNAJC7 p.Arg156Ter variant compared to four healthy controls.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31768050","rdfs:label":"Effects of DNAJC7 PTV p.Arg156Ter on protein levels","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11c1d60a-ca71-49e8-b022-32b5ca5ce017","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11c1d60a-ca71-49e8-b022-32b5ca5ce017_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33193563","allele":{"id":"https://genegraph.clinicalgenome.org/r/0ac845cf-bece-41da-82a8-c68ee3065493","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.712A>G (p.Arg238Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399528189"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f6016342-fab3-4e86-801f-45d2f507ecc1","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6016342-fab3-4e86-801f-45d2f507ecc1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35039179","allele":{"id":"https://genegraph.clinicalgenome.org/r/d61c3b95-8370-4063-a840-b2e774df3f98","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.1021A>C (p.Thr341Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399525972"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/207ec416-8a60-49f1-8138-565b71c6a4b4","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/207ec416-8a60-49f1-8138-565b71c6a4b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31768050","allele":{"id":"https://genegraph.clinicalgenome.org/r/0cd5045e-151a-4082-8c45-485b0cae5d19","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.1273G>A (p.Glu425Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399524058"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cf6bbe25-e7d8-49a3-82fc-ee98fbced99b","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf6bbe25-e7d8-49a3-82fc-ee98fbced99b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33193563","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d49b168-1ddf-4ff4-a449-b1402a8653a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.281G>C (p.Ser94Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8570012"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/16d7ae67-cbc9-454d-b1dc-48ee96950909","type":"EvidenceLine","dc:description":"Absent from gnomAD non-neuro cohort.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16d7ae67-cbc9-454d-b1dc-48ee96950909_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33062890","allele":{"id":"https://genegraph.clinicalgenome.org/r/929afa29-b367-4d4a-bae8-9398816a4175","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.401_402del (p.Gln134ArgfsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573331904"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8d60fba3-e9b7-4657-949f-b71652367b31","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d60fba3-e9b7-4657-949f-b71652367b31_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34233860","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7252e1e-1683-40c7-adfe-377303f8aecc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.1012T>A (p.Tyr338Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399526023"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9428e602-bd34-4b1d-9f4a-644482130416","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9428e602-bd34-4b1d-9f4a-644482130416_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35039179","allele":{"id":"https://genegraph.clinicalgenome.org/r/9829012b-3ec2-4414-9fa8-3fe8c0a4136d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.1031A>G (p.Tyr344Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399525919"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/11619154-1441-43d8-a10b-e0b2b6bc530d","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11619154-1441-43d8-a10b-e0b2b6bc530d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35039179","allele":{"id":"https://genegraph.clinicalgenome.org/r/9887e3eb-fcad-4e79-8561-fca4cab21359","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.495G>C (p.Met165Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399529784"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/323ad6ae-b9f1-4dff-b5ab-4bc9c74d776d","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/323ad6ae-b9f1-4dff-b5ab-4bc9c74d776d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35039179","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d1f78fe-b820-4481-82cf-3ea6361629e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.1447+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399521060"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d518e692-c398-460e-a276-7190b942f466","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d518e692-c398-460e-a276-7190b942f466_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35039179","allele":{"id":"https://genegraph.clinicalgenome.org/r/c0e2306d-486b-491e-a20f-423a9166d352","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.293G>T (p.Gly98Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399532817"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e2a12a19-b37a-4654-87fa-3a921c202c87_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a4d9548-121d-42a4-814f-3e428bf152f0","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a4d9548-121d-42a4-814f-3e428bf152f0_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31768050","rdfs:label":"Farhan2019 extended cohort (5,095 cases vs 28,910 controls)","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/c7d1f9bd-add6-4988-8c0b-d88cfc2346ee","type":"Cohort","allGenotypedSequenced":5095,"alleleFrequency":0.001570166830225712,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a4d9548-121d-42a4-814f-3e428bf152f0_cc_evidence_item"}],"numWithVariant":8,"relatedCondition":{"id":"obo:MONDO_0004976"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/2776ddd9-852b-4bc6-9071-2a7110c0dfde","type":"Cohort","allGenotypedSequenced":28910,"alleleFrequency":0,"detectionMethod":"7,839 WES in-house and 21,071 WES in ExAC.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a4d9548-121d-42a4-814f-3e428bf152f0_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":2.5E-7,"statisticalSignificanceType":"","statisticalSignificanceValue":96.6,"statisticalSignificanceValueType":"Odds Ratio"}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/39ef5100-a5db-41a5-afb5-ddb2926f7227","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39ef5100-a5db-41a5-afb5-ddb2926f7227_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31768050","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb08d75e-8627-47dc-9a24-e5a208e217cc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.631G>A (p.Asp211Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399528580"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/995b8cf6-9e0d-43e0-8ac9-2e1d7a976869","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/995b8cf6-9e0d-43e0-8ac9-2e1d7a976869_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31768050","allele":{"id":"https://genegraph.clinicalgenome.org/r/9866d1c4-a5af-47b7-ba8c-313c73dc0e0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.1234C>T (p.Arg412Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399524148"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ccef0304-3f56-47cd-844a-dfb824717874","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ccef0304-3f56-47cd-844a-dfb824717874_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35039179","allele":{"id":"https://genegraph.clinicalgenome.org/r/1977bd32-1c1e-4855-ab8b-d9a4fc66b074","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.62A>C (p.Asp21Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA399536154"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/35ea899e-93ea-4f91-9de9-1d3bc3228cf5","type":"EvidenceLine","dc:description":"The ALS GCEP resolved that as no statistical genetic evidence currently exists to support the role of missense variants in disease, only protein truncating variants in DNAJC7 are eligible for variant scoring.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35ea899e-93ea-4f91-9de9-1d3bc3228cf5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32897108","allele":{"id":"https://genegraph.clinicalgenome.org/r/3208cd0b-bfc0-43ca-b0b5-e8e60620fe1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003315.4(DNAJC7):c.410A>G (p.Lys137Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA290713540"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Limited","sequence":5523,"specifiedBy":"GeneValidityCriteria9","strengthScore":5.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ko6VyVkkvt8","type":"GeneValidityProposition","disease":"obo:MONDO_0004976","gene":"hgnc:12392","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e2a12a19-b37a-4654-87fa-3a921c202c87-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}